TIGIT and hepatocellular carcinoma: While we observed a small increase in TIGIT expression on CD56bright pbNK cells co-cultured with hepatoma cells in the transwell condition, CD56bright pbNK cells upregulated TIGIT expression more strongly following direct contact with human hepatoma cells, and this upregulation was significantly reduced, but not fully suppressed, in the presence of an antibody blocking PVR.